Market Overview:

The structural heart devices market is a dynamic and rapidly evolving sector within the medical device industry. It primarily deals with medical devices and technologies designed to treat various structural abnormalities and defects of the heart. These structural heart conditions can include issues like heart valve disorders, congenital heart defects, and other structural anomalies that affect the normal functioning of the heart.

  1. Growing Aging Population: The aging population is at a higher risk of developing heart-related conditions, and as the global population continues to age, the demand for structural heart devices is expected to increase.
  2. Advancements in Technology: Technological advancements have led to the development of minimally invasive procedures and innovative devices, such as transcatheter heart valves and closure devices, which are less invasive and offer quicker recovery times for patients.
  3. Increasing Incidence of Heart Diseases: Heart diseases remain a leading cause of death worldwide. The rising prevalence of conditions like valvular heart diseases and atrial fibrillation is driving the demand for structural heart devices.

The global structural heart devices market is to grow from USD 12.4 billion in 2022 to USD 32.2 billion by 2032, at a CAGR of 10.3% during the forecast period 2022-2032.

For insights on global, regional, and country-level parameters with growth opportunities from 2023 to 2032 – Please check this report:https://market.us/report/structural-heart-devices-market/

Market Demands :

  1. Minimally Invasive Procedures: There is a growing demand for minimally invasive structural heart procedures. Patients prefer these less invasive options as they typically involve shorter hospital stays, quicker recovery times, and reduced pain and scarring.
  2. Transcatheter Heart Valves: The demand for transcatheter heart valves, such as those used in TAVR (Transcatheter Aortic Valve Replacement) and TMVR (Transcatheter Mitral Valve Repair), is on the rise. These devices offer a viable alternative to open-heart surgery for valve replacement and repair.
  3. Patient-Centric Care: Patients are increasingly seeking personalized care. As a result, there is a demand for structural heart devices that can be tailored to individual patient needs, ensuring the best possible outcomes.
  4. Treatment for High-Risk Patients: Structural heart devices that cater to high-risk patients who are not suitable candidates for traditional surgeries are in demand. These devices offer a lifeline to individuals who may have limited treatment options otherwise.
  5. Wide Range of Device Options: Patients and healthcare providers seek a wide range of structural heart device options to address various conditions, including heart valve disorders, congenital defects, and atrial fibrillation. Having a variety of devices allows for more precise treatment.
  6. Affordability and Accessibility: Affordable structural heart devices are in demand to make treatment accessible to a broader patient population. Cost-effective solutions and insurance coverage are essential to meet this demand.
  7. Improved Durability and Longevity: Patients and healthcare providers expect structural heart devices to be durable and long-lasting. These devices should provide reliable treatment over an extended period, reducing the need for frequent replacements or revisions.
  8. Training and Education: There is a growing demand for training and education programs for healthcare professionals to become proficient in performing structural heart procedures. Ensuring that an adequate number of skilled specialists are available to meet the demand is crucial.

Market Regional Analysis

–North America [United States, Canada, Mexico]
-South America [Brazil, Argentina, Columbia, Chile, Peru]
-Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
-Middle East & Africa [GCC, North Africa, South Africa]
-Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]

 

Market Key Players:

  • Boston Scientific Corporation
  • Edwards Lifesciences Corporation
  • Abbott
  • LivaNova PLC
  • Medtronic
  • JenaValve Technology, Inc.
  • Comed BV
  • CardioKinetix
  • Other Key Players

Market Top Segmentations:

Based on Product

  • Heart Valve Devices
  • Annuloplasty Rings
  • Surgical Heart Valves
  • Occluders and Delivery Systems
  • Transcatheter Heart Valves
  • Other Products

Based on Indication

  • Atrial Septal Defect
  • Patent Foramen Ovale
  • Ventricular Septal Defect
  • Aortic Valve Stenosis
  • Other Indications

Based on Procedure

  • Replacement Procedures
  • Repair Procedures
  • TAVR Procedures
  • SAVR Procedures
  • Valvuloplasty
  • Annuloplasty
  • TMVR Procedures

Based on End-User

  • Hospitals
  • Ambulatory Surgical Centers
  • Other End-Users

Make an inquiry before picking up this report  @https://market.us/report/structural-heart-devices-market/#inquiry

Market Recent development:

  1. Transcatheter Technologies Dominating: Transcatheter technologies, such as transcatheter aortic valve replacement (TAVR) and transcatheter mitral valve repair (TMVR), have gained significant traction in recent years. The market has witnessed the introduction of advanced transcatheter devices, offering less invasive alternatives to surgical procedures.
  2. Percutaneous Mitral Valve Repair: Percutaneous mitral valve repair devices, like the MitraClip, continue to evolve and gain acceptance. Recent developments include improved device iterations and expanding indications for use, making mitral valve repair more accessible to a broader range of patients.
  3. Left Atrial Appendage Closure (LAAC): LAAC devices, used to reduce the risk of stroke in patients with atrial fibrillation, have seen advancements in device design and clinical evidence. These developments have led to increased adoption and a broader range of LAAC device options.
  4. PFO Closure Devices: Patent foramen ovale (PFO) closure devices have seen innovations, making PFO closure procedures more effective in preventing paradoxical embolism. Newer devices are designed for improved safety and ease of use.
  5. 3D Printing and Personalized Devices: 3D printing technology is being employed to create patient-specific structural heart devices, particularly for congenital heart defects.

Contact:

Global Business Development Team – Market.us

Market.us (Powered by Prudour Pvt. Ltd.)

Send Email: inquiry@market.us

Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Tel: +1 718 618 4351

Website: https://market.us